A Critical Study on Acylating and Covalent Reversible Fragment Inhibitors of SARS‐CoV‐2 Main Protease Targeting the S1 Site with Pyridine
SARS coronavirus main proteases (3CL proteases) have been validated as
pharmacological targets for the treatment of coronavirus infections. Current inhibitors of …
pharmacological targets for the treatment of coronavirus infections. Current inhibitors of …